Tactile Systems Technology Inc (TCMD)
15.62
-0.61
(-3.76%)
USD |
NASDAQ |
Nov 14, 16:00
15.69
+0.07
(+0.45%)
After-Hours: 17:52
Tactile Systems Technology Research and Development Expense (Quarterly): 2.417M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 2.417M |
June 30, 2024 | 2.234M |
March 31, 2024 | 2.143M |
December 31, 2023 | 1.793M |
September 30, 2023 | 1.964M |
June 30, 2023 | 1.833M |
March 31, 2023 | 2.233M |
December 31, 2022 | 2.139M |
September 30, 2022 | 1.581M |
June 30, 2022 | 1.849M |
March 31, 2022 | 1.52M |
December 31, 2021 | 1.774M |
September 30, 2021 | 1.409M |
June 30, 2021 | 1.206M |
March 31, 2021 | 1.27M |
December 31, 2020 | 1.373M |
September 30, 2020 | 1.102M |
June 30, 2020 | 1.105M |
March 31, 2020 | 1.684M |
December 31, 2019 | 1.192M |
Date | Value |
---|---|
September 30, 2019 | 1.467M |
June 30, 2019 | 1.234M |
March 31, 2019 | 1.281M |
December 31, 2018 | 1.34M |
September 30, 2018 | 1.223M |
June 30, 2018 | 1.289M |
March 31, 2018 | 1.437M |
December 31, 2017 | 1.361M |
September 30, 2017 | 1.116M |
June 30, 2017 | 1.465M |
March 31, 2017 | 1.118M |
December 31, 2016 | 1.162M |
September 30, 2016 | 1.285M |
June 30, 2016 | 1.049M |
March 31, 2016 | 0.98M |
December 31, 2015 | 1.39M |
September 30, 2015 | 1.094M |
June 30, 2015 | 1.011M |
March 31, 2015 | 0.817M |
December 31, 2014 | 0.912M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.102M
Minimum
Sep 2020
2.417M
Maximum
Sep 2024
1.691M
Average
1.729M
Median
Research and Development Expense (Quarterly) Benchmarks
InfuSystems Holdings Inc | -- |
Perspective Therapeutics Inc | 9.275M |
Retractable Technologies Inc | 0.1991M |
Xtant Medical Holdings Inc | 0.636M |
Catheter Precision Inc | 0.081M |